T. Rowe Price Associates’s Taylor Morrison TMHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.49M | Buy |
111,383
+13,812
| +14% | +$863K | ﹤0.01% | 1328 |
|
|
2025
Q4 | $5.75M | Buy |
97,571
+2,215
| +2% | +$135K | ﹤0.01% | 1348 |
|
|
2025
Q3 | $6.29M | Buy |
95,356
+2,233
| +2% | +$147K | ﹤0.01% | 1334 |
|
|
2025
Q2 | $5.72M | Sell |
93,123
-1,086
| -1% | -$63.1K | ﹤0.01% | 1237 |
|
|
2025
Q1 | $5.66M | Buy |
94,209
+8,071
| +9% | +$502K | ﹤0.01% | 1226 |
|
|
2024
Q4 | $5.27M | Buy |
86,138
+8,205
| +11% | +$560K | ﹤0.01% | 1279 |
|
|
2024
Q3 | $5.48M | Buy |
77,933
+2,748
| +4% | +$176K | ﹤0.01% | 1268 |
|
|
2024
Q2 | $4.17M | Sell |
75,185
-3,712
| -5% | -$212K | ﹤0.01% | 1280 |
|
|
2024
Q1 | $4.91M | Buy |
78,897
+2,028
| +3% | +$112K | ﹤0.01% | 1223 |
|
|
2023
Q4 | $4.1M | Buy |
76,869
+2,586
| +3% | +$116K | ﹤0.01% | 1265 |
|
|
2023
Q3 | $3.17M | Buy |
74,283
+2,874
| +4% | +$135K | ﹤0.01% | 1312 |
|
|
2023
Q2 | $3.48M | Buy |
71,409
+1,357
| +2% | +$58.4K | ﹤0.01% | 1297 |
|
|
2023
Q1 | $2.68M | Buy |
70,052
+1,643
| +2% | +$57.7K | ﹤0.01% | 1364 |
|
|
2022
Q4 | $2.08M | Sell |
68,409
-2,055
| -3% | -$57.3K | ﹤0.01% | 1444 |
|
|
2022
Q3 | $1.64M | Buy |
70,464
+10,359
| +17% | +$269K | ﹤0.01% | 1529 |
|
|
2022
Q2 | $1.4M | Buy |
60,105
+974
| +2% | +$25.8K | ﹤0.01% | 1738 |
|
|
2022
Q1 | $1.61M | Buy |
59,131
+5,440
| +10% | +$166K | ﹤0.01% | 1783 |
|
|
2021
Q4 | $1.88M | Sell |
53,691
-4,631
| -8% | -$145K | ﹤0.01% | 1744 |
|
|
2021
Q3 | $1.5M | Sell |
58,322
-11,861
| -17% | -$314K | ﹤0.01% | 1850 |
|
|
2021
Q2 | $1.85M | Sell |
70,183
-1,908
| -3% | -$56.7K | ﹤0.01% | 1772 |
|
|
2021
Q1 | $2.22M | Buy |
72,091
+1,194
| +2% | +$33.5K | ﹤0.01% | 1675 |
|
|
2020
Q4 | $1.82M | Sell |
70,897
-483
| -0.7% | -$12.3K | ﹤0.01% | 1674 |
|
|
2020
Q3 | $1.75M | Buy |
71,380
+9,999
| +16% | +$236K | ﹤0.01% | 1590 |
|
|
2020
Q2 | $1.18M | Buy |
61,381
+196
| +0.3% | +$3.09K | ﹤0.01% | 1711 |
|
|
2020
Q1 | $673K | Buy |
61,185
+8,445
| +16% | +$182K | ﹤0.01% | 1850 |
|
|
2019
Q4 | $1.15M | Buy |
52,740
+18,713
| +55% | +$450K | ﹤0.01% | 1832 |
|
|
2019
Q3 | $883K | Buy |
34,027
+396
| +1% | +$9.12K | ﹤0.01% | 1871 |
|
|
2019
Q2 | $705K | Buy |
33,631
+250
| +0.7% | +$4.97K | ﹤0.01% | 1983 |
|
|
2019
Q1 | $593K | Buy |
33,381
+300
| +0.9% | +$5.36K | ﹤0.01% | 2061 |
|
|
2018
Q4 | $526K | Buy |
33,081
+15,756
| +91% | +$257K | ﹤0.01% | 2057 |
|
|
2018
Q3 | $313K | Buy |
17,325
+385
| +2% | +$7.65K | ﹤0.01% | 2342 |
|
|
2018
Q2 | $352K | Buy |
16,940
+134
| +0.8% | +$2.98K | ﹤0.01% | 2296 |
|
|
2018
Q1 | $391K | Buy |
16,806
+7,774
| +86% | +$194K | ﹤0.01% | 2179 |
|
|
2017
Q4 | $221K | Buy |
+9,032
| New | +$211K | ﹤0.01% | 2395 |
|
|
2017
Q3 | – | Sell |
-8,972
| Closed | -$215K | – | 2587 |
|
|
2017
Q2 | $215K | Buy |
+8,972
| New | +$207K | ﹤0.01% | 2351 |
|
|
2016
Q3 | – | Sell |
-12,900
| Closed | -$191K | – | 2560 |
|
|
2016
Q2 | $191K | Hold |
12,900
| – | – | ﹤0.01% | 2345 |
|
|
2016
Q1 | $182K | Hold |
12,900
| – | – | ﹤0.01% | 2313 |
|
|
2015
Q4 | $206K | Buy |
12,900
+100
| +0.8% | +$1.76K | ﹤0.01% | 2295 |
|
|
2015
Q3 | $239K | Hold |
12,800
| – | – | ﹤0.01% | 2229 |
|
|
2015
Q2 | $261K | Hold |
12,800
| – | – | ﹤0.01% | 2252 |
|
|
2015
Q1 | $267K | Hold |
12,800
| – | – | ﹤0.01% | 2238 |
|
|
2014
Q4 | $242K | Buy |
12,800
+1,400
| +12% | +$25K | ﹤0.01% | 2275 |
|
|
2014
Q3 | $185K | Sell |
11,400
-169,400
| -94% | -$3.3M | ﹤0.01% | 2369 |
|
|
2014
Q2 | $4.05M | Buy |
180,800
+22,600
| +14% | +$489K | ﹤0.01% | 1482 |
|
|
2014
Q1 | $3.72M | Sell |
158,200
-286,593
| -64% | -$6.47M | ﹤0.01% | 1467 |
|
|
2013
Q4 | $9.99M | Sell |
444,793
-451,591
| -50% | -$9.72M | ﹤0.01% | 1284 |
|
|
2013
Q3 | $20.3M | Sell |
896,384
-37,496
| -4% | -$846K | 0.01% | 1073 |
|
|
2013
Q2 | $22.8M | Buy |
+933,880
| New | +$23.6M | 0.01% | 1035 |
|
Other funds holding TMHC
VPM
VCM
T. Rowe Price Associates's TMHC Position: Q1 2026 in Review
T. Rowe Price Associates increased its Taylor Morrison (TMHC) stake by 14% in Q1 2026, buying an estimated $863K and bringing the position to 111,383 shares worth $6.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1328.
T. Rowe Price Associates first reported a position in TMHC in Q2 2013 and has held it in 48 quarters since. The position peaked at $22.8M in Q2 2013. 449 funds tracked by Wall St. Rank hold TMHC as of Q1 2026.
- T. Rowe Price Associates held 111,383 shares of Taylor Morrison worth $6.49M as of Q1 2026.
- T. Rowe Price Associates bought 13,812 Taylor Morrison shares in Q1 2026, an estimated $863K.
- Taylor Morrison made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1328 holding.
- T. Rowe Price Associates first reported a position in Taylor Morrison in Q2 2013 and has held it in 48 quarters since.
- T. Rowe Price Associates's Taylor Morrison position peaked at $22.8M in Q2 2013.
- 449 funds tracked by Wall St. Rank held Taylor Morrison as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.